Sitagliptininhibits DPP-4, leading to stabilization of the short-lived incretin peptides GLP-1 and GIP.The use of DPP-4 inhibitors in managing hyperglycemia in adults with T2D varies based onlocal practice guidelines [8]. Here, GCG is linked to type 2 diabetes mellitus.